Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tanja Fehm

Showing results (311-320 of 371) with videos related to

Pageof 38
Sort By:
Clinical Chemistry|January 4, 2024
Efficacy of Lapatinib in Patients with HER2-Negative Metastatic Breast Cancer and HER2-Positive Circulating Tumor Cells-The DETECT III Clinical TrialTanja Fehm, Volkmar Mueller, Maggie Banys-Paluchowski, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 26, 2013
Diagnostic leukapheresis enables reliable detection of circulating tumor cells of nonmetastatic cancer patientsJohannes C Fischer, Dieter Niederacher, Stefan A Topp, et al.
Breast (Edinburgh, Scotland)|April 5, 2025
Clinical characteristics and prognostic factors in patients with breast cancer and leptomeningeal metastases from a large registry of BMBCElena Laakmann, Marcus Schmidt, Kristina Lübbe, et al.
International Journal of Cancer|January 30, 2019
Evaluation of soluble carbonic anhydrase IX as predictive marker for efficacy of bevacizumab: A biomarker analysis from the geparquinto phase III neoadjuvant breast cancer trialMelanie Janning, Volkmar Müller, Eik Vettorazzi, et al.
Vaccine|March 7, 2021
Immunogenicity and safety of a nine-valent human papillomavirus vaccine in women 27-45 years of age compared to women 16-26 years of age: An open-label phase 3 studyElmar A Joura, Angels Ulied, Corinne Vandermeulen, et al.
Nature|December 16, 2016
Early dissemination seeds metastasis in breast cancerHedayatollah Hosseini, Milan M S Obradović, Martin Hoffmann, et al.
Molecular Cancer|November 14, 2023
Ultra-sensitive CTC-based liquid biopsy for pancreatic cancer enabled by large blood volume analysisNikolas H Stoecklein, Georg Fluegen, Rosa Guglielmi, et al.
Lancet (London, England)|April 22, 2023
Trastuzumab deruxtecan versus treatment of physician's choice in patients with HER2-positive metastatic breast cancer (DESTINY-Breast02): a randomised, open-label, multicentre, phase 3 trialFabrice André, Yeon Hee Park, Sung-Bae Kim, et al.
BMJ Open|August 3, 2021
Study protocol for a mixed methods exploratory investigation of aftercare services for gestational diabetes in women to develop a new patient-centred model in Germany: the GestDiNa_basic studyGregory Gordon Greiner, Anja Viehmann, Ute Linnenkamp, et al.
Annals of Surgical Oncology|November 30, 2016
Outcome After Sentinel Lymph Node Dissection in Vulvar Cancer: A Subgroup Analysis of the AGO-CaRE-1 StudyRüdiger Klapdor, Peter Hillemanns, Linn Wölber, et al.
Pageof 38

Showing results (311-320 of 371) with videos related to

Sort By:
Pageof 38
Clinical Chemistry|January 4, 2024
Efficacy of Lapatinib in Patients with HER2-Negative Metastatic Breast Cancer and HER2-Positive Circulating Tumor Cells-The DETECT III Clinical TrialTanja Fehm, Volkmar Mueller, Maggie Banys-Paluchowski, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 26, 2013
Diagnostic leukapheresis enables reliable detection of circulating tumor cells of nonmetastatic cancer patientsJohannes C Fischer, Dieter Niederacher, Stefan A Topp, et al.
Breast (Edinburgh, Scotland)|April 5, 2025
Clinical characteristics and prognostic factors in patients with breast cancer and leptomeningeal metastases from a large registry of BMBCElena Laakmann, Marcus Schmidt, Kristina Lübbe, et al.
International Journal of Cancer|January 30, 2019
Evaluation of soluble carbonic anhydrase IX as predictive marker for efficacy of bevacizumab: A biomarker analysis from the geparquinto phase III neoadjuvant breast cancer trialMelanie Janning, Volkmar Müller, Eik Vettorazzi, et al.
Vaccine|March 7, 2021
Immunogenicity and safety of a nine-valent human papillomavirus vaccine in women 27-45 years of age compared to women 16-26 years of age: An open-label phase 3 studyElmar A Joura, Angels Ulied, Corinne Vandermeulen, et al.
Nature|December 16, 2016
Early dissemination seeds metastasis in breast cancerHedayatollah Hosseini, Milan M S Obradović, Martin Hoffmann, et al.
Molecular Cancer|November 14, 2023
Ultra-sensitive CTC-based liquid biopsy for pancreatic cancer enabled by large blood volume analysisNikolas H Stoecklein, Georg Fluegen, Rosa Guglielmi, et al.
Lancet (London, England)|April 22, 2023
Trastuzumab deruxtecan versus treatment of physician's choice in patients with HER2-positive metastatic breast cancer (DESTINY-Breast02): a randomised, open-label, multicentre, phase 3 trialFabrice André, Yeon Hee Park, Sung-Bae Kim, et al.
BMJ Open|August 3, 2021
Study protocol for a mixed methods exploratory investigation of aftercare services for gestational diabetes in women to develop a new patient-centred model in Germany: the GestDiNa_basic studyGregory Gordon Greiner, Anja Viehmann, Ute Linnenkamp, et al.
Annals of Surgical Oncology|November 30, 2016
Outcome After Sentinel Lymph Node Dissection in Vulvar Cancer: A Subgroup Analysis of the AGO-CaRE-1 StudyRüdiger Klapdor, Peter Hillemanns, Linn Wölber, et al.
Pageof 38